missing translation for 'onlineSavingsMsg'
Learn More

Novus Biologicals™ LINGO-1 Antibody (opicinumab), Novus Biologicals™

Human Monoclonal Antibody

Brand:  Novus Biologicals™ NBP3-28533-100ug

 View more versions of this product

Product Code. 30047400

  • 326.00€ / 100µg

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

LINGO-1 Monoclonal antibody specifically detects LINGO-1 in Human samples. It is validated for Flow Cytometry,ELISA,Functional Assay
TRUSTED_SUSTAINABILITY
Specifications

Specifications

LINGO-1
Monoclonal
Unconjugated
Q96FE5
Human
Protein A purified
RUO
Primary
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Store at -20°C in powder form. Store at -80°C once reconstituted.
IgG1
Flow Cytometry, ELISA, Functional Assay
opicinumab
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
FLJ14594, LERN1UNQ201, leucine rich repeat and Ig domain containing 1, leucine rich repeat neuronal 6A, Leucine-rich repeat and immunoglobilin domain-containing protein 1, Leucine-rich repeat neuronal protein 1, Leucine-rich repeat neuronal protein 6A, LRRN6Aleucine-rich repeat neuronal 6A, MGC17422
LINGO1
100 μg
Neuroscience
84894
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.